Literature DB >> 7825527

Effects of cafestol and kahweol from coffee grounds on serum lipids and serum liver enzymes in humans.

R Urgert1, A G Schulz, M B Katan.   

Abstract

The diterpenes cafestol and kahweol are present in unfiltered coffee in oil droplets and floating fines. They elevate serum cholesterol and alanine aminotransferase (ALT). We measured fines in coffee brews, and examined diterpene availability from spent grounds in healthy volunteers. Turkish or Scandinavian boiled coffee contained 2-5 g fines/L and French press coffee contained 1.5 g fines/L. An intake of 8 g fine grounds/d for 3 wk increased cholesterol by 0.65 mmol/L (95% CI 0.41-0.89 mmol/L) and ALT by 18 U/L (95% CI 4-32 U/L) relative to control subjects (n = 7/group). In a crossover study (n = 15), mean serum cholesterol was 4.9 mmol/L after consumption of both fine and coarse grounds for 10 d (P = 0.43). Serum ALT activities were 29 U/L on fine and 21 U/L on coarse grounds (P = 0.02). Floating fines could contribute substantially to the hyperlipidemic and ALT-elevating effect of unfiltered coffee. Diterpene measurements in coffee brews should include the contribution of fines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7825527     DOI: 10.1093/ajcn/61.1.149

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  11 in total

1.  Influence of coffee brew in metabolic syndrome and type 2 diabetes.

Authors:  Sheila Andrade Abrahão; Rosemary Gualberto Fonseca Alvarenga Pereira; Raimundo Vicente de Sousa; Adriene Ribeiro Lima; Gabriela Previatti Crema; Bianca Sacramento Barros
Journal:  Plant Foods Hum Nutr       Date:  2013-06       Impact factor: 3.921

Review 2.  Coffee Drinking and Reduced Risk of Liver Cancer: Update on Epidemiological Findings and Potential Mechanisms.

Authors:  Manami Inoue; Shoichiro Tsugane
Journal:  Curr Nutr Rep       Date:  2019-09

3.  Comparison of effect of cafetière and filtered coffee on serum concentrations of liver aminotransferases and lipids: six month randomised controlled trial.

Authors:  R Urgert; S Meyboom; M Kuilman; H Rexwinkel; M N Vissers; M Klerk; M B Katan
Journal:  BMJ       Date:  1996-11-30

4.  Effect of unfiltered coffee on carbon tetrachloride-induced liver injury in rats.

Authors:  Orhan Kursat Poyrazoglu; Ibrahim Halil Bahcecioglu; Huseyin Ataseven; Kerem Metin; Adile Ferda Dagli; Mehmet Yalniz; Bilal Ustundag
Journal:  Inflammation       Date:  2008-12       Impact factor: 4.092

5.  Cholesterol-raising diterpenes in types of coffee commonly consumed in Singapore, Indonesia and India and associations with blood lipids: a survey and cross sectional study.

Authors:  Nasheen Naidoo; Cynthia Chen; Salome A Rebello; Karl Speer; E Shyong Tai; Jeanette Lee; Sandra Buchmann; Isabelle Koelling-Speer; Rob M van Dam
Journal:  Nutr J       Date:  2011-05-15       Impact factor: 3.271

Review 6.  The cholesterol-raising factor from coffee beans.

Authors:  R Urgert; M B Katan
Journal:  J R Soc Med       Date:  1996-11       Impact factor: 18.000

7.  Boiled coffee consumption and the risk of prostate cancer: follow-up of 224,234 Norwegian men 20-69 years.

Authors:  A Tverdal
Journal:  Br J Cancer       Date:  2014-12-23       Impact factor: 7.640

8.  Coffee bean extracts rich and poor in kahweol both give rise to elevation of liver enzymes in healthy volunteers.

Authors:  Mark V Boekschoten; Evert G Schouten; Martijn B Katan
Journal:  Nutr J       Date:  2004-07-15       Impact factor: 3.271

9.  Reproducibility of the serum lipid response to coffee oil in healthy volunteers.

Authors:  Mark V Boekschoten; Mariëlle F Engberink; Martijn B Katan; Evert G Schouten
Journal:  Nutr J       Date:  2003-10-04       Impact factor: 3.271

10.  Effect of caffeine-containing beverage consumption on serum alanine aminotransferase levels in patients with chronic hepatitis C virus infection: a hospital-based cohort study.

Authors:  Yachiyo Sasaki; Satoko Ohfuji; Wakaba Fukushima; Akihiro Tamori; Masaru Enomoto; Daiki Habu; Shuji Iwai; Sawako Uchida-Kobayashi; Hideki Fujii; Susumu Shiomi; Norifumi Kawada; Yoshio Hirota
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.